{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:24:45Z","timestamp":1761506685763,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jamda.2019.12.006","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T19:05:52Z","timestamp":1579806352000},"page":"143-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clarifying the Relationship Between Benzodiazepines and Dementia"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-4212","authenticated-orcid":false,"given":"Randall T.","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2019.12.006_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of Alzheimer's disease, 2000-2050: Potential implication of treatment advances","volume":"23","author":"Sloane","year":"2002","journal-title":"Annu Rev Pub Health"},{"key":"10.1016\/j.jamda.2019.12.006_bib3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2019.12.006_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease","volume":"378","author":"Egan","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2019.12.006_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/cts.12491","article-title":"Lessons learned from Alzheimer disease: Clinical trials with negative outcomes","volume":"11","author":"Cummings","year":"2018","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jamda.2019.12.006_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.aau0437","article-title":"Alzheimer's disease: The right drug, the right time","volume":"362","author":"Golde","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jamda.2019.12.006_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2105\/AJPH.2014.301935","article-title":"Characterization of dementia and Alzheimer's disease in an older population: Updated incidence and life expectancy with and without dementia","volume":"105","author":"Tom","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jamda.2019.12.006_bib8","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2019.12.006_bib9","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American\u00a0Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2019.12.006_bib11","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: Case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.12.006_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bcp.12705","article-title":"Indication bias or protopathic bias?","volume":"80","author":"Faillie","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2019.12.006_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamda.2019.08.017","article-title":"Uncertain association between benzodiazepine use and the risk of dementia: A cohort study","volume":"21","author":"Baek","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.12.006_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jamda.2019.08.006","article-title":"Cognitive outcomes of long term benzodiazepine and related drug (BZDR) use in people living with mild-to-moderate Alzheimer disease: Results from NILVAD","volume":"21","author":"Dyer","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.12.006_bib15","doi-asserted-by":"crossref","first-page":"e1002660","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jamda.2019.12.006_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jamda.2019.05.010","article-title":"Association of benzodiazepine and anticholinergic drug usage with incident dementia: A prospective cohort study of community-dwelling older adults","volume":"21","author":"Hafdi","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.12.006_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): A cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2019.12.006_bib18","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.2017.4628","article-title":"Beyond medication reconciliation: The correct medication list","volume":"317","author":"Rose","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.12.006_bib19","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: The D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.12.006_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pop.2017.04.003","article-title":"Managing polypharmacy in the 15-minute office visit","volume":"44","author":"Antimisiaris","year":"2017","journal-title":"Prim Care"},{"key":"10.1016\/j.jamda.2019.12.006_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing benzodiazepines in older patients: Impact of interventions targeting physicians, pharmacists, and patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs Aging"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101930845X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101930845X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:19:52Z","timestamp":1761506392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586101930845X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S152586101930845X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2019.12.006","relation":{},"ISSN":["1525-8610"],"issn-type":[{"type":"print","value":"1525-8610"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clarifying the Relationship Between Benzodiazepines and Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}